Health Guide · Thyroid Health
Your thyroid shapes
every signal on
your wearable
Thyroid dysfunction - hypothyroidism and hyperthyroidism - produces opposite but equally measurable effects on HRV, resting heart rate, sleep, and energy. Ziva tracks these signatures continuously and monitors whether your treatment is working beyond just a blood test number.
Isabella · Thyroid treatment response — Week 6
Levothyroxine started 6 weeks ago
Improving
HRV recovering toward baseline. RHR trending down. Sleep efficiency improving.
HRV — 6-week trend
41 ms ↑ from 29 ms
Resting HR
72 bpm ↓ from 81 bpm
Sleep efficiency
76% ↑ from 62%
Energy score
Still improving not yet at baseline
"Your HRV has recovered 12 ms in 6 weeks - your autonomic nervous system is responding to the levothyroxine. RHR is still above your pre-illness baseline. Your next TSH test in 2 weeks will tell us whether the dose is optimal."
How Thyroid Hormone Works
The thyroid sets the metabolic
pace of every organ
The thyroid gland produces T4 (thyroxine) and T3 (triiodothyronine) - hormones that regulate metabolism, heart rate, body temperature, brain function, digestion, muscle strength, and mood. Every cell in the body has thyroid hormone receptors. When thyroid output is off in either direction, the downstream effects are broad and measurable - including in your wearable data every single night.
The hypothalamic-pituitary-thyroid (HPT) axis regulates thyroid output: low thyroid hormone triggers the pituitary to release more TSH (thyroid-stimulating hormone), which tells the thyroid to produce more T4. High thyroid hormone suppresses TSH. This is why TSH is the primary screening test - it reflects the pituitary's assessment of whether thyroid output is adequate.
T4 → T3 conversion — where most action happens
T4 is a prohormone - it's converted to the active T3 in peripheral tissues (liver, kidneys, muscle) by deiodinase enzymes. Many people on T4-only treatment (levothyroxine) have normal T4 and TSH but suboptimal T3 - and continue to feel unwell. Wearable HRV can reflect this inadequate conversion even when standard labs look normal.
Direct cardiac effects
Thyroid hormone has direct genomic effects on cardiac muscle - regulating ion channel expression, myosin heavy chain isoforms, and the sensitivity of the heart to catecholamines. This is why both hypo and hyperthyroidism alter heart rate and HRV so profoundly and so consistently.
Autonomic nervous system modulation
Thyroid hormone modulates the balance between sympathetic and parasympathetic nervous system activity. Hypothyroidism blunts autonomic responsiveness overall - reducing both arms of the ANS but disproportionately impairing vagal (parasympathetic) tone. Hyperthyroidism drives sympathetic dominance - mimicking a chronic fight-or-flight state.
Thyroid function → wearable signals
Hypothyroid (underactive)
TSH high · T3/T4 low
HRV↓
vagal tone blunted
RHR↑
paradoxically elevated
Sleep↓
fragmented, unrefreshing
Hyperthyroid (overactive)
TSH low · T3/T4 high
HRV↓↓
sympathetic surge
RHR↑↑
often 90–120 bpm
Sleep↓↓
insomnia, anxiety
Optimal thyroid function
TSH 1–2.5 · T3/T4 mid-range
HRV↑
strong vagal tone
RHR✓
at personal baseline
Sleep✓
restorative deep sleep
Why wearables are uniquely useful for thyroid monitoring
TSH tells you whether the pituitary thinks thyroid output is adequate. Your wearable tells you whether the heart, autonomic nervous system, and sleep architecture agree. These two measures answer different questions - and they don't always align. Isabella uses the wearable data to give your care team a continuous, objective picture of how your autonomic nervous system is responding to your current thyroid status.
Hypothyroidism
When the thyroid slows down,
everything slows with it
Hypothyroidism - an underactive thyroid - is the most common thyroid disorder. It affects approximately 5% of the US population, with women 5–8× more affected than men. The wearable signature is distinctive: reduced HRV, paradoxically elevated resting heart rate, fragmented sleep, and persistently low energy scores that don't respond to rest.
HRV — suppressed
Hypothyroidism reduces cardiac autonomic modulation - specifically blunting parasympathetic (vagal) tone. HRV is a direct measure of this. Multiple studies confirm that HRV is significantly lower in hypothyroid patients than in euthyroid (normal) controls, and that it improves with treatment. The suppression is proportional to the degree of hypothyroidism - subclinical cases show milder but still measurable HRV changes.
Resting HR — paradoxically elevated
Counter-intuitively, hypothyroidism raises resting heart rate in many cases - not because the heart is beating efficiently, but because of impaired diastolic function, peripheral vascular resistance, and reduced cardiac output requiring compensatory rate increases. This is often missed because "slow pulse = hypothyroid" is taught as a simplification that doesn't reflect clinical reality.
Sleep — unrefreshing despite duration
Hypothyroid patients frequently report sleeping 9–10 hours but waking exhausted. Wearable data reveals why: reduced deep sleep percentage and poor sleep efficiency despite adequate total sleep time. The thyroid hormone-dependent slowing of metabolic processes impairs the neural activity needed for quality restorative sleep - including the growth hormone pulses that occur during deep sleep.
Balance Check — a common pattern
The hypothyroid wearable signature - HRV below baseline, RHR above baseline, elevated respiratory rate - closely resembles Ziva's Balance Check pattern. Unlike dehydration or illness (which resolve within days), the hypothyroid pattern persists for weeks and doesn't respond to rest, hydration, or lifestyle changes. This persistence is what prompts Isabella to suggest thyroid function testing.
Subclinical hypothyroidism matters
Subclinical hypothyroidism - elevated TSH with normal T4, typically asymptomatic by clinical criteria - still shows measurable HRV suppression in wearable data. Studies show that wearable cardiac autonomic measures can detect thyroid dysfunction at TSH levels that fall within or near the upper end of the "normal" reference range. This makes wearable monitoring a useful early-warning system even before labs show definitive abnormality.
I
Isabella
Persistent low HRV pattern
"Your HRV has been below your baseline for 8 consecutive weeks with no training load, illness, or significant stress to explain it. Resting HR is consistently 7–9 bpm above your historical average and your deep sleep percentage has dropped from 18% to 11%. This pattern is persistent and non-responsive to rest — which is unusual. It's consistent with thyroid dysfunction, sleep apnoea, or chronic anaemia. I'd suggest asking your doctor to check TSH, free T4, T3, and a full blood count at your next visit."
8 weeks
persistent HRV below baseline
+8 bpm
RHR above average
11%
deep sleep % (↓ from 18%)
Common hypothyroid symptoms alongside wearable changes
Persistent fatigue not improved by sleep
Unexplained weight gain or difficulty losing weight
Cold intolerance — feeling cold when others don't
Brain fog, slowed thinking, poor memory
Hair thinning, dry skin, brittle nails
Constipation, slowed digestion
Depression or low mood without clear cause
Hyperthyroidism
When the thyroid overdrive —
the heart pays the price
Hyperthyroidism - an overactive thyroid - produces the opposite wearable signature: resting heart rate often above 90 bpm, severely suppressed HRV, insomnia, anxiety, and weight loss despite appetite. The cardiovascular effects are significant - persistent hyperthyroidism increases atrial fibrillation risk and puts the heart under sustained metabolic stress.
Resting HR — markedly elevated
90–120 bpm
Excess T3 directly increases sinus node firing rate, myocardial contractility, and catecholamine sensitivity. Sustained resting HR above 90 bpm is a common presentation - and is visible as a persistent upward trend in Ziva's resting HR data.
HRV — severely suppressed
Chronically low
Sympathetic dominance driven by excess thyroid hormone eliminates the normal beat-to-beat variability. HRV can drop to levels typically seen in severe illness or over-training. The heart is beating fast and consistently - high rate, low variability is a clear hyperthyroid pattern.
AFib risk
5× higher
Hyperthyroidism increases atrial fibrillation risk approximately 5-fold. Some wearables (Apple Watch, Withings) can detect AFib through irregular rhythm detection. Isabella monitors heart rate pattern irregularity alongside HRV and flags concerning patterns for provider review.
Common hyperthyroid symptoms — alongside wearable changes
Heart racing or palpitations (elevated RHR, reduced HRV)
Weight loss despite increased appetite
Anxiety, tremor, irritability (sympathetic surge)
Heat intolerance, excessive sweating
Insomnia — inability to fall or stay asleep
Muscle weakness, fatigue despite hyperactivity
Frequent bowel movements
I
Isabella
Hyperthyroid alert pattern
"Your resting heart rate has been above 95 bpm every night for 3 weeks — 33 bpm above your 12-month average. HRV has dropped to the lowest recorded value in your data. You've also logged poor sleep and anxiety most days. This pattern — sustained high RHR, very low HRV, sleep disruption — is not consistent with lifestyle factors alone. Please see your doctor soon. I've prepared a summary of the last 4 weeks of wearable data for you to bring."
97 bpm
avg resting HR — 3 weeks
Lowest
HRV on record
Hashimoto's Thyroiditis
The autoimmune cause - and why
wearable data fluctuates
Hashimoto's thyroiditis is the most common cause of hypothyroidism in the US - an autoimmune condition where the immune system attacks the thyroid gland. The inflammatory nature of Hashimoto's creates wearable patterns that fluctuate more than simple hypothyroidism: immune flares produce periods of worsened HRV suppression and elevated resting heart rate independent of current thyroid hormone levels.
Hashitoxicosis — the swing phase
As the immune attack destroys thyroid cells, stored thyroid hormone can spill into the bloodstream - causing temporary hyperthyroid symptoms (racing heart, anxiety, insomnia) before eventual hypothyroidism develops. Isabella detects this as sudden unexplained increases in resting HR and HRV suppression even when TSH is stable - the wearable often detects the swing before a blood test is scheduled.
Inflammation drives wearable changes directly
Systemic inflammation - present during Hashimoto's flares - independently suppresses HRV and raises resting heart rate, separate from thyroid hormone levels. HRV can be below baseline during a flare even when TSH is technically "in range." This explains why many treated Hashimoto's patients still feel unwell despite normal labs - their inflammatory load remains elevated.
Gluten, diet, and Hashimoto's
Molecular mimicry between gliadin (wheat protein) and thyroid tissue antigens means gluten can trigger immune activity in some Hashimoto's patients - and this immune activation shows in wearable data. Some patients show measurable HRV improvement and RHR reduction after 12+ weeks of strict gluten elimination. Isabella tracks these dietary changes in the Nutrition section and correlates them with wearable trends.
Selenium and thyroid peroxidase antibodies
Selenium is required for thyroid hormone synthesis and antioxidant protection of thyroid cells. Studies show selenium supplementation (200 mcg/day) reduces thyroid peroxidase antibody (TPO Ab) levels in Hashimoto's patients and may slow disease progression. Log supplementation in Ziva and Isabella tracks the correlation with your HRV trend over months.
Isabella's Hashimoto's tracking approach
For Hashimoto's patients, wearable variation comes from two distinct sources: thyroid hormone-related changes that track with TSH, and inflammation-driven changes that track with dietary triggers and stress load. Logging dietary changes and stress events alongside your wearable data creates a longitudinal picture that helps explain why you feel worse on some days than others - even when your last blood test was fine.
Key nutrients for Hashimoto's — track in Ziva Nutrition
Selenium - supports T4→T3 conversion and reduces antibodies. Brazil nuts, tuna, eggs.
Iodine - essential but excess worsens Hashimoto's. Avoid high-dose supplements.
Vitamin D - immune modulation. Deficiency associated with higher antibody levels.
Zinc - required for T3 receptor binding and conversion. Common deficiency in Hashimoto's.
Gluten - trial elimination (12+ weeks) for patients with positive TPO Ab to assess wearable response.
Treatment Monitoring
Normal TSH doesn't always mean
you feel normal
The most common frustration in thyroid treatment: TSH is "in range" but symptoms persist - fatigue, brain fog, poor sleep. Wearable data provides an objective measure of whether your autonomic nervous system has actually normalised, not just whether a lab number has moved into a reference range. These are different questions.
HRV as a treatment response marker
As thyroid hormone replacement therapy normalises levels, HRV measurably improves - typically within 6–12 weeks of reaching adequate dose. The rate of HRV improvement tracks the return of vagal tone. Isabella plots your HRV trend against treatment start date and any dose changes, giving your doctor an objective timeline of response.
T4-only vs. combination therapy
Some patients on T4-only treatment normalise TSH but maintain persistently suppressed HRV and poor sleep - suggesting inadequate T3 at tissue level. Wearable data showing ongoing HRV suppression despite normal TSH provides objective evidence for your doctor to consider a combination therapy approach that supports better T3 availability.
Dose optimisation window
The optimal TSH range for symptom resolution is often narrower than the laboratory reference range (0.5–4.5 mIU/L). Many patients feel best with TSH between 0.5 and 2.0. HRV peaks at this range and declines at both extremes. Isabella can show whether your wearable data suggests treatment is insufficient (persistently suppressed HRV, high RHR) or excessive (HRV low in a sympathetic pattern, sleep disrupted).
Consistent treatment timing — wearable matters
Thyroid medication should be taken consistently - same time, same conditions relative to food and coffee. Irregular timing produces variable hormone absorption, which creates day-to-day HRV fluctuations that can confuse the treatment monitoring picture. Log your treatment in Ziva and Isabella can identify whether inconsistent timing is contributing to your wearable variability.
I
Isabella
Treatment response — 12 weeks
"Your TSH is now 1.8 and your endocrinologist is satisfied with the dose. Your HRV has recovered from 27 ms to 44 ms — still 8 ms below your pre-illness baseline of 52 ms. Your deep sleep is 14% — still below your historical 19%. This pattern — TSH normal but HRV and sleep not fully recovered — suggests your T3 levels at tissue level may not be optimal. It might be worth discussing free T3 testing and whether a combination therapy approach would close the remaining gap."
44 ms
HRV (up from 27)
−8 ms
below pre-illness baseline
14%
deep sleep % (was 19%)
What to log for thyroid treatment tracking
Thyroid treatment — start date and any changes
Lab results (TSH, free T4, free T3, TPO antibodies)
Dose changes — Isabella marks these on your HRV timeline
Supplements (selenium, vitamin D, zinc)
Dietary changes (gluten elimination trial)
Sleep & Energy
Sleep is both a symptom
and a lever for thyroid patients
Thyroid dysfunction disrupts sleep architecture directly. But optimising sleep quality is also one of the most effective ways to support thyroid health - poor sleep raises TSH, impairs T4→T3 conversion, and worsens the fatigue that defines thyroid dysfunction. Ziva tracks both directions of this relationship.
Hypothyroid sleep
Long but unrefreshing. Reduced deep sleep percentage. Normal or increased total duration. Waking tired. Isabella detects the mismatch between sleep duration and next-morning HRV recovery - long sleep that produces poor HRV recovery is characteristic.
Hyperthyroid sleep
Insomnia - difficulty initiating and maintaining sleep. High overnight heart rate visible on wearable. Anxiety-driven wakefulness. Short sleep despite exhaustion. Isabella tracks overnight heart rate elevation as a key hyperthyroid sleep signal.
Supporting sleep
Evening breathing programs (4-7-8, coherent breathing) improve sleep onset and deep sleep percentage in thyroid patients by activating vagal tone - compensating for the parasympathetic blunting of hypothyroidism. Available in Ziva's breathing library.
Sleep and TSH — the bidirectional relationship
TSH secretion follows a circadian rhythm - peaking during sleep and declining in the early morning. Poor sleep and sleep deprivation raise TSH independently of thyroid function, potentially masking treatment adequacy or creating false abnormal results. For thyroid patients, this means consistently poor sleep can make your thyroid function look worse than it is on lab tests. Isabella tracks your sleep quality in the context of your thyroid treatment to help your provider interpret results correctly - and notes when your TSH test was preceded by poor sleep in the provider report.
How Ziva Tracks Thyroid Health
Continuous monitoring that
no quarterly lab can provide
TSH every 3–6 months tells you where your thyroid is at a point in time. Ziva watches HRV, resting heart rate, sleep, and energy every night - showing how your autonomic nervous system is responding to your current thyroid status between labs.
Labs
What to test, what it means,
and how Ziva adds context
Thyroid labs are snapshots. Wearable data is continuous. Together they give a complete picture of thyroid health - what the hormones are doing and how the body is actually responding.
TSH
Primary screening test. Normal range: 0.4–4.5 mIU/L (lab-dependent). Optimal for most treated patients: 0.5–2.0. High TSH = hypothyroid. Low/suppressed TSH = hyperthyroid or over-treated. Test annually when stable, every 6–8 weeks when adjusting dose.
Annual / dose changes
Free T4 & Free T3
Free T4: active T4 level (normal 0.8–1.8 ng/dL). Free T3: active T3 level (normal 2.3–4.2 pg/mL) - the hormone that actually acts on cells. Low-normal free T3 with normal TSH and T4 suggests conversion impairment. Correlates directly with HRV - Isabella flags when wearable data suggests poor T3 status.
With TSH, especially if symptomatic
TPO & Thyroglobulin Antibodies
Thyroid peroxidase antibodies (TPO Ab) confirm Hashimoto's. Elevated in 90%+ of Hashimoto's cases. Thyroglobulin antibodies (TgAb) provide additional confirmation. Elevated antibodies with normal TSH = subclinical autoimmune thyroiditis. High antibody levels correlate with higher inflammatory load and greater HRV impact.
At diagnosis / annually for Hashimoto's
Reverse T3
In high stress, illness, or caloric restriction, the body converts T4 to reverse T3 (rT3) instead of active T3 - blocking T3 receptors without providing metabolic benefit. This produces hypothyroid-like symptoms with normal TSH and T4. Elevated rT3 with low-normal free T3 explains persistent fatigue despite apparently adequate treatment. HRV correlates with rT3/T3 ratio.
When symptomatic despite normal TSH/T4
Selenium & Vitamin D
Selenium deficiency impairs T4→T3 conversion and thyroid peroxidase activity. Vitamin D deficiency is strongly associated with Hashimoto's and worsens autoimmune activity. Both are common and easily corrected - test levels and supplement if deficient. Log supplementation in Ziva and Isabella tracks the wearable response over 12+ weeks.
At diagnosis and annually
Ziva Lab Integration
Upload your thyroid labs and Isabella places them in the context of your HRV trend, sleep data, and logged medication. A TSH of 2.1 means something different when your HRV has been rising for 8 weeks than when it's been falling - Isabella gives your provider both data points in a single report.
Science Deep Dive
Common questions, answered
01
Why do I still feel tired when my TSH is normal?
Several mechanisms explain this common frustration. First, T4-only treatment may produce normal TSH with suboptimal free T3 at tissue level - the hormone that actually acts on cells. Second, the "normal" TSH range (0.4–4.5) is wide; many patients feel best within a narrower range (0.5–2.0). Third, inflammation from Hashimoto's suppresses HRV independently of thyroid hormone levels. Fourth, reverse T3 can block T3 receptors during stress or restriction. Wearable HRV data often shows persistent suppression in these cases - providing objective evidence for your doctor to investigate beyond TSH alone.
02
How quickly does HRV improve after starting thyroid treatment?
HRV improvements typically begin within 4–6 weeks of reaching an adequate levothyroxine dose, with most improvement occurring over 3–6 months. The rate mirrors the slow rise in serum T4 and the gradual recovery of cardiac autonomic function. Some patients with concurrent T3 deficiency or ongoing inflammation see slower HRV recovery despite normalised TSH. Isabella tracks this trajectory from the date of prescription entry and can show your provider exactly how your autonomic response compares to the expected timeline - useful when deciding whether a dose adjustment is needed.
03
Can exercise help thyroid function?
Yes, in several ways. Regular aerobic exercise improves T4→T3 conversion efficiency, reduces reverse T3, improves the HRV that thyroid dysfunction suppresses, and reduces the inflammation that drives Hashimoto's activity. However, excessive high-intensity exercise in hypothyroid patients can backfire - high training loads raise cortisol, which impairs T4→T3 conversion and raises rT3. Isabella monitors your training load relative to your current HRV baseline and recommends appropriate intensity - lighter when thyroid status is suboptimal, more when treatment is working well.
04
Is subclinical hypothyroidism worth treating?
This is genuinely debated in endocrinology. Current guidelines generally reserve treatment for TSH above 10 mIU/L or for symptomatic patients at any TSH elevation. However, wearable data adds a dimension that guidelines don't yet incorporate: some patients with TSH of 4–6 (within the reference range) show persistent HRV suppression, elevated resting heart rate, and poor sleep that improves with treatment - suggesting their individual optimal range is lower than population norms. Isabella identifies this pattern and presents it as objective evidence for a nuanced conversation with your provider about whether a therapeutic trial is warranted.
FAQ
Frequently asked
Isabella doesn't diagnose thyroid conditions - that's for your doctor. What she does is identify patterns that are inconsistent with lifestyle explanations. When HRV is persistently suppressed for 6–8 weeks without training load, illness, stress, dehydration, or sleep changes to explain it - and when it doesn't respond to the interventions that typically help - Isabella flags thyroid dysfunction as one of several possible explanations worth investigating, alongside sleep apnoea, anaemia, and chronic inflammation. She presents this alongside your provider report so your doctor has the objective wearable context when reviewing your labs.
Yes - log levothyroxine in Ziva's medication section and set a daily reminder. Consistent timing is important for stable T4 absorption: take it on an empty stomach, 30–60 minutes before food, coffee, or other medications, at the same time each day. Calcium, iron, antacids, and some medications impair absorption and should be taken at least 4 hours apart. Isabella uses your medication log to correlate dosing consistency with your HRV trend - inconsistent timing often shows as day-to-day HRV variability.
Yes, in pattern. Simple hypothyroidism (e.g. post-radioiodine or post-surgical) produces a stable, consistent HRV suppression that recovers steadily on treatment. Hashimoto's produces more variable wearable data - flares of additional HRV suppression driven by immune activity that don't correlate neatly with TSH changes. This day-to-day variability in a treated patient with otherwise stable TSH is itself informative - it suggests ongoing inflammatory activity from the autoimmune process that may warrant additional investigation or dietary/lifestyle intervention.
The Oura Ring provides the most comprehensive overnight HRV, resting heart rate, sleep architecture, and skin temperature data - particularly valuable for thyroid monitoring where overnight measurements are most informative and free from exercise artefact. The Apple Watch Series 9+ also provides high-quality overnight HR data and includes AFib detection relevant for hyperthyroid monitoring. WHOOP provides excellent HRV and recovery scoring. All three integrate with Ziva. The most important factor is wearing it consistently - the value comes from long-term trend data, not single readings.
Yes - it's directly relevant. Ziva generates provider reports summarising your HRV trend, resting heart rate, sleep efficiency, and any notable patterns correlated with your medication log and lab entries. Many patients find their endocrinologist is receptive to objective wearable data showing persistent autonomic suppression despite normal TSH - it supports the clinical case for investigating free T3, reverse T3, or a dose adjustment. The report presents data in clinical format rather than consumer dashboard terms.
Ziva Health
Know if your thyroid treatment
is actually working
Log your medication, upload your labs, and let Isabella track whether your HRV, resting heart rate, and sleep are recovering as your thyroid treatment takes effect - and flag when the data suggests your dose may need review.